Skip to content

Simplexa™ GBS Direct MOL3550

by DiaSorin Molecular LLC

Ref MOL3550

Simplexa GBS Direct MOL3550 (MOL5290) is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II; EMDN category strep. b detection by na reagents) made by DiaSorin Molecular LLC, registered in EUDAMED on 9 Oct 2026 (Basic UDI-DI B-20816101025644), cleared under FDA 510(k) K182467 on 7 Nov 2018 and listed in FDA GUDID since 20 Nov 2018 (UDI-DI 20816101025644), active as of 7 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 7 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K182467

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-20816101025644 Basic UDI-DI 20816101025644UDI-DIDate9 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number20816101025644 UDI-DI Date20 Nov 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK182467 Date7 Nov 2018DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-20816101025644 registered 9 Oct 2026 Active
  • FDA 510(k) K182467 decided 7 Nov 2018 Active
  • FDA GUDID UDI-DI 20816101025644 listed 20 Nov 2018 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K182467
  2. Listed FDA GUDID 20816101025644
  3. Registered EUDAMED B-20816101025644

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Simplexa™ GBS Direct
Generic name
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
MOL3550, MOL5290
Primary DI / UDI-DI
20816101025644
Basic UDI-DI
B-20816101025644
510(k) Number
FDA product code
OOI, NJR
EMDN code
W0105011104 Strep. b detection by na reagents
GMDN term
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
862.2570, 866.3740
EU registration type
Legacy device (under a directive)
EU market of registration
Italy
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under STREP. B DETECTION BY NA REAGENTS.

Other devices from DiaSorin Molecular LLC

See all devices from DiaSorin Molecular LLC →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)